ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances OCC Q1 2026 Earnings Net Loss of 005 Per Share Stock Climbs 788 PLPC Q1 2026 Earnings EPS Surges 15 Above Estimates Amid Resilient Operations RDWR Q1 2026 Earnings EPS Misses Estimates Stock Declines 298 CBAN Q1 2026 Earnings EPS Misses Expectations but Stock Edges Higher CVKD Q1 2026 Earnings Narrower Loss Surprises Clinical Progress Maintained PAM Q1 2026 Earnings Staggering EPS Beat as Operating Performance Surges CSRS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges EGBN Q1 2026 Earnings EPS Surges Past Estimates on Strong Margin and Lower Provisions Workhorse Group Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Tenet Healthcare THC Q1 2026 Earnings Strong EPS Beat Masks Market Skepticism WATT Q1 2026 Earnings NarrowerthanExpected Loss Reflects Effective Cost Control JLL Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Uncertainty